Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 123 | 85 | 50 | 53 | 40 |
| Cost of Goods | 60 | 61 | 20 | 19 | 19 |
| Gross Profit | 63 | 24 | 31 | 34 | 22 |
| Operating Expenses | 1,346 | 365 | 547 | 442 | 1,316 |
| Operating Income | -1,223 | -280 | -496 | -389 | -1,276 |
| Interest Expense | 13 | 37 | 47 | 196 | 50 |
| Other Income | 0 | 983 | -3,496 | -2,295 | -4,860 |
| Pre-tax Income | -1,236 | 667 | -4,039 | -2,879 | -6,185 |
| Net Income Continuous | -1,236 | 667 | -4,039 | -2,879 | -6,185 |
| Net Income | $-1,236 | $667 | $-4,039 | $-2,879 | $-6,185 |
| EPS Basic Total Ops | -460.00 | 1,720.00 | -3,180.00 | -2,420.00 | -5,640.00 |
| EPS Basic Continuous Ops | -468.90 | 1,699.24 | -3,176.86 | -2,406.63 | -5,638.29 |
| EPS Diluted Total Ops | -460.00 | 1,720.00 | -3,180.00 | -2,420.00 | -5,640.00 |
| EPS Diluted Continuous Ops | -468.90 | 1,699.24 | -3,176.86 | -2,406.63 | -5,638.29 |
| EBITDA(a) | $-1,220 | $-276 | $-493 | $-385 | $-1,273 |